Drugs / 68Ga-FAPI-JNU
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06684028 | Jul 2023 → Jul 2025 overdue | cancer | Affiliated Hospital of Jiangnan University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 68Ga-FAPI-JNU | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06684028 ↗ |
| Modality | Diagnostic / imaging agent | “DIAGNOSTIC” NCT06684028 ↗ |
| Route | Intravenous | “68Ga-FAPI-JNU is administered through a superficial vein on the back of the hand” NCT06684028 ↗ |